Although we complemented the JMSU1-based system with J82-RS cells as an independent FGFR1-expressing resistant model, further validation using additional FGFR1-dependent bladder cancer models, such as UMUC3, would strengthen the generalizability of our findings. This evidence concerns the gene FGFR1 and urinary bladder cancer.